. 2020 Jul 1;94(14):e02128-19. doi: 10.1128/JVI.02128-19

TABLE 4.

Epitope sequences and samples for longitudinal analysis

Patient	HLA-B*57	Epitope	Time point(s) (wpi^c )
P1	pos	TSTLQEQIGW	17
		LSPRTLNAW	271
		KAFSPEIIPMF	271
P2	pos	ISPRTLNAW	195
		KAFSPEVIPMF	195
P3	pos	HTQGYFPDWQ	274
		KAFSPEVIPMF	274
P4	pos	KAFSPEVIPMF	181, 227, 316
		QASQEVKNW	181, 227, 316
P5	pos	TSTLQEQIGW	16
		KAFSPEVIPMF	144, 309
		ISPRTLNAW	144
		QASQEVKNW	309
P6	pos	ISPRTLNAW	26
		KAFSPEVIPMF	26, 277
		LSPRTLNAW	277^a
P7	neg	KRWIILGLNK	10, 59, 131, 178, 225, 274, 321
		GPGHKARVL	10, 59, 131, 178
		GPSHKARVL	10
P8	neg	RLRPGGKKR	10, 86, 139
P9	neg	ETINEEAAEW	10^a , 60, 109, 155
P10	neg	TPQDLNTML	10^a, 87, 159^b, 204^a, 229, 276
P11	neg	RLRPGGKKK	8, 79, 126
		ETINEEAAEW	8
P12	neg	EVYKKWII	14, 62, 133

Only data from functional panel available.

Only data from exhaustion panel available.

wpi, estimated number of weeks postinfection.